Greenland Capital Management’s Pfizer PFE Stock Holding History

Greenland Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-25,000	Closed	-$700K	–	416
2024 Q2	$700K	Buy	+25,000	New	+$688K	0.1%	157

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Greenland Capital Management's PFE Position: Q1 2025 in Review

Greenland Capital Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 13,087 shares — an estimated $347K sold.

Greenland Capital Management first reported a position in PFE in Q2 2024 and held it in 3 quarters. The position peaked at $810K in Q3 2024. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Greenland Capital Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Greenland Capital Management sold 13,087 Pfizer shares in Q1 2025, an estimated $347K.
Greenland Capital Management first reported a position in Pfizer in Q2 2024 and held it in 3 quarters.
Greenland Capital Management's Pfizer position peaked at $810K in Q3 2024.
2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Greenland Capital Management's 13F filing for Q1 2025, filed 12 May 2025.